Advertisement
Screener

Evome Medical Technologies, Inc. Proceeds from Stock Options Exercised

Evome Medical Technologies, Inc. Proceeds from Stock Options Exercised

Evome Medical Technologies, Inc. reported Proceeds from Stock Options Exercised of CAD 33.90 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromStockOptionsExercised · last filed 2024-04-16

  • Evome Medical Technologies, Inc. proceeds from stock options exercised for the quarter ending 2023-12-31 was 0.00 CAD.
  • Evome Medical Technologies, Inc. proceeds from stock options exercised for the quarter ending 2023-09-30 was 0.00 CAD.
  • Evome Medical Technologies, Inc. proceeds from stock options exercised for the quarter ending 2023-06-30 was 0.00 CAD, a 100.00% decline year-over-year.
  • Evome Medical Technologies, Inc. proceeds from stock options exercised for the quarter ending 2023-03-31 was 33.90K CAD.
  • Evome Medical Technologies, Inc. proceeds from stock options exercised for fiscal 2023 was 33.90K CAD.
  • Evome Medical Technologies, Inc. proceeds from stock options exercised for fiscal 2022 was 376.89K CAD, a 6947.34% increase from fiscal 2021.
  • Evome Medical Technologies, Inc. proceeds from stock options exercised for fiscal 2021 was 5.35K CAD.
Period endProceeds from Stock Options Exercised 1 monthProceeds from Stock Options Exercised 3 monthProceeds from Stock Options Exercised 6 monthProceeds from Stock Options Exercised 9 monthProceeds from Stock Options Exercised 9 month as first filedProceeds from Stock Options Exercised 10 monthProceeds from Stock Options Exercised 12 month
2023-12-310.00 CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
0.00 CAD
derived: sum of 2 quarters · filed 2024-04-16
0.00 CAD
derived: sum of 3 quarters · filed 2024-04-16
33.90K CAD
10-K · filed 2024-04-16
2023-09-300.00 CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
0.00 CAD
derived: sum of 2 quarters · filed 2023-11-14
33.90K CAD
10-Q · filed 2023-11-14
2023-06-300.00 CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
33.90K CAD
10-Q · filed 2023-08-14
2023-03-3133.90K CAD
10-Q · filed 2023-05-15
2022-12-315.33K CAD
10-K · filed 2024-04-16
2022-11-300.00 CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17
5.33K CAD
10-Q · filed 2023-01-17
2022-09-300.00 CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
5.33K CAD
10-Q · filed 2023-11-14
2022-08-310.00 CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17
5.33K CAD
10-Q · filed 2022-10-17
2022-06-305.33K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
5.33K CAD
10-Q · filed 2023-08-14
2022-05-315.33K CAD
10-Q · filed 2022-07-15
2022-03-310.00 CAD
10-Q · filed 2023-05-15
2022-02-28-1.00 CAD
derived: 10-KT 12 month − 10-Q 9 month · filed 2023-04-03
0.00 CAD
derived: sum of 2 quarters · filed 2023-04-03
200.89K CAD
derived: sum of 3 quarters · filed 2023-04-03
376.89K CAD
10-KT · filed 2023-04-03
2021-12-31376.89K CAD
10-KT · filed 2023-04-03
2021-11-301.00 CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17
200.89K CAD
derived: sum of 2 quarters · filed 2023-01-17
376.89K CAD
10-Q · filed 2023-01-17
376.89K CAD
10-Q · filed 2022-01-14
376.89K CAD
derived: sum of 4 quarters · filed 2023-01-17
2021-08-31200.89K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17
376.89K CAD
10-Q · filed 2022-10-17
376.89K CAD
derived: sum of 3 quarters · filed 2022-10-17
382.24K CAD
derived: sum of 4 quarters · filed 2022-10-17
2021-08-2021.39K CAD
10-K · filed 2022-05-31
2021-05-31176.00K CAD
10-Q · filed 2022-07-15
176.00K CAD
derived: sum of 2 quarters · filed 2022-07-15
181.35K CAD
derived: sum of 3 quarters · filed 2022-07-15
2021-05-20355.50K CAD
10-KT · filed 2023-04-03
2021-02-280.00 CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
5.35K CAD
derived: sum of 2 quarters · filed 2022-05-31
5.35K CAD
10-K · filed 2022-05-31
2020-11-305.35K CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-01-14
5.35K CAD
10-Q · filed 2022-01-14
2020-10-225.35K CAD
10-KT · filed 2023-04-03
2020-08-310.00 CAD
10-Q · filed 2021-10-15